{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:25:55Z","timestamp":1789233955903,"version":"build-2803163510"},"reference-count":266,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.trim.2025.102304","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:14:03Z","timestamp":1760220843000},"page":"102304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Immunomodulation in post-transplant diabetes mellitus: Challenges and management"],"prefix":"10.1016","volume":"93","author":[{"given":"Hanan","family":"Maoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Elalouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2025.102304_bb0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/atm.2018.09.68","article-title":"Solid organ transplantation in the 21st century","volume":"6","author":"Black","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/08998280.2021.1985889","article-title":"The history of organ transplantation","volume":"35","author":"Nordham","year":"2022","journal-title":"Baylor Univ. Med. Cent. Proc."},{"key":"10.1016\/j.trim.2025.102304_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.57603\/EJT-403","article-title":"Review of the history of living donor solid organ transplants","volume":"2","author":"Vella","year":"2024","journal-title":"Eur. J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1101\/cshperspect.a014985","article-title":"Why is organ transplantation clinically important?","volume":"3","author":"Griny\u00f3","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000445","article-title":"Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: results from the HRS-HARMONY consortium","volume":"30","author":"Li","year":"2024","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2025.102304_bb0030","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.3390\/jcm13144188","article-title":"Surgical strategies for renal transplantation: a pictorial essay","volume":"13","author":"Novacescu","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0035","doi-asserted-by":"crossref","DOI":"10.4291\/wjgp.v15.i6.94590","article-title":"Exploring the current provision of pancreatic transplantations in low- and middle-income countries: current landscape, challenges, future prospects","volume":"15","author":"Bharadwaj","year":"2024","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"10.1016\/j.trim.2025.102304_bb0040","article-title":"Minimally invasive surgical techniques for kidney transplantation","volume":"2017","author":"Uwechue","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/ijem.IJEM_178_19","article-title":"Prevalence and predictors of \u201cnew-onset diabetes after transplantation\u201d (NODAT) in renal transplant recipients: an observational study","volume":"23","author":"Choudhury","year":"2019","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2024.1336896","article-title":"Post-transplant diabetes mellitus: risk factors and outcomes in a 5-year follow-up","volume":"5","author":"Rossi","year":"2024","journal-title":"Front. Clin. Diabetes Healthc."},{"key":"10.1016\/j.trim.2025.102304_bb0055","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3390\/jcm13071928","article-title":"New-onset diabetes mellitus after kidney transplantation","volume":"13","author":"Alajous","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0060","series-title":"Single-Centre Data: Incidence, Risk Factors, and Effect on Graft Function and Mortality","first-page":"99","article-title":"Post-transplant diabetes mellitus in renal transplant recipients","volume":"29","author":"Kumar","year":"2023"},{"key":"10.1016\/j.trim.2025.102304_bb0065","first-page":"175","article-title":"New onset diabetes after transplantation (NODAT): an overview, diabetes","volume":"4","author":"Pham","year":"2011","journal-title":"Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.trim.2025.102304_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/diabetology3010007","article-title":"Novel insights into the immunotherapy-based treatment strategy for autoimmune type 1 diabetes","volume":"3","author":"Rathod","year":"2022","journal-title":"Diabetology"},{"key":"10.1016\/j.trim.2025.102304_bb0075","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/193229680900300213","article-title":"The role of immunomodulation therapy in autoimmune diabetes","volume":"3","author":"Ludvigsson","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.trim.2025.102304_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.smim.2011.07.003","article-title":"Immune intervention in type 1 diabetes","volume":"23","author":"Michels","year":"2011","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101565","article-title":"Beta cell and immune cell interactions in autoimmune type 1 diabetes: how they meet and talk to each other","volume":"64","author":"Scherm","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0090","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/cells13191662","article-title":"Inflammatory trajectory of type 2 diabetes: novel opportunities for early and late treatment","volume":"13","author":"Pellegrini","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.trim.2025.102304_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur. Cardiol. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s13167-010-0010-9","article-title":"Diabetes mellitus: new challenges and innovative therapies","volume":"1","author":"Sena","year":"2010","journal-title":"EPMA J."},{"key":"10.1016\/j.trim.2025.102304_bb0105","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.cell.2024.06.029","article-title":"Diabetes mellitus\u2014Progress and opportunities in the evolving epidemic","volume":"187","author":"Abel","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.trim.2025.102304_bb0110","doi-asserted-by":"crossref","first-page":"1206874","DOI":"10.3389\/fimmu.2023.1206874","article-title":"Monitoring immunomodulation strategies in type 1 diabetes","volume":"14","author":"Krishnamurthy","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1590\/S1676-24442011000100006","article-title":"Immunomodulatory effects of oral antidiabetic drugs in lymphocyte cultures from patients with type 2 diabetes","volume":"47","author":"Mello","year":"2011","journal-title":"J. Bras. Patol. e Med. Lab."},{"key":"10.1016\/j.trim.2025.102304_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-024-05226-3","article-title":"Advances and challenges of the cell-based therapies among diabetic patients","volume":"22","author":"Raoufinia","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.607473","article-title":"Chronic hyperglycemia drives functional impairment of lymphocytes in diabetic INSC94Y transgenic Pigs","volume":"11","author":"Giese","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.trim.2025.102304_bb0135","first-page":"442","article-title":"Type 2 diabetes and its impact on the immune system","volume":"16","author":"Berbudi","year":"2019","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.trim.2025.102304_bb0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/antib12010020","article-title":"Intravenous immunoglobulins as immunomodulators in autoimmune diseases and reproductive medicine","volume":"12","author":"Velikova","year":"2023","journal-title":"Antibodies"},{"key":"10.1016\/j.trim.2025.102304_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127704","article-title":"Immunomodulation\u2014a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system","volume":"14","author":"Strzelec","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1075813","article-title":"The emerging role of regulatory cell-based therapy in autoimmune disease","volume":"13","author":"Ghobadinezhad","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2023.1095467","article-title":"Impact of diabetes mellitus on immunity to latent tuberculosis infection","volume":"4","author":"Kumar","year":"2023","journal-title":"Front. Clin. Diabetes Healthc."},{"key":"10.1016\/j.trim.2025.102304_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01582","article-title":"The effects of type 2 diabetes mellitus on organ metabolism and the immune system","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0165","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.3390\/ijms25137105","article-title":"Pathology of diabetes-induced immune dysfunction","volume":"25","author":"Alexander","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2025.102304_bb0170","first-page":"1","article-title":"Advanced glycation end products and diabetic complications, Korean","volume":"18","author":"Singh","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.trim.2025.102304_bb0175","series-title":"Adv. Clin. Chem., Adv Clin Chem","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.acc.2022.11.003","article-title":"Protein glycation in diabetes mellitus","author":"Shin","year":"2023"},{"key":"10.1016\/j.trim.2025.102304_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/1179551419844521","article-title":"Therapies for type 1 diabetes: current scenario and future perspectives","volume":"12","author":"Pathak","year":"2019","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"10.1016\/j.trim.2025.102304_bb0185","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00125-021-05398-3","article-title":"Current and future therapies for type 1 diabetes","volume":"64","author":"von Scholten","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.trim.2025.102304_bb0190","article-title":"Diabetes mellitus and immunomodulation: a double-edged sword","volume":"1","author":"Harte","year":"2021","journal-title":"Int. Undergrad. J. Heal. Sci."},{"key":"10.1016\/j.trim.2025.102304_bb0195","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized medicine: motivation, challenges, and progress","volume":"109","author":"Goetz","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.trim.2025.102304_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2024.1436842","article-title":"Strategies and delivery systems for cell-based therapy in autoimmunity","volume":"4","author":"Puccetti","year":"2024","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.trim.2025.102304_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2017.05.013","article-title":"Combinatorial drug delivery approaches for immunomodulation","volume":"114","author":"Stewart","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/er.2015-1084","article-title":"Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes","volume":"37","author":"Shivaswamy","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb0215","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1111\/dom.15575","article-title":"An update review of post-transplant diabetes mellitus: concept, risk factors, clinical implications and management, diabetes","volume":"26","author":"Kanbay","year":"2024","journal-title":"Obes. Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0220","first-page":"42","article-title":"Diabetes mellitus post kidney transplant","volume":"49","author":"Ouellette","year":"2024","journal-title":"U.S. Pharm."},{"key":"10.1016\/j.trim.2025.102304_bb0225","series-title":"Post-transplant Diabetes Mellitus","volume":"19","author":"Chowdhury","year":"2019"},{"key":"10.1016\/j.trim.2025.102304_bb0230","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/jcm13030793","article-title":"Diabetic kidney disease in post-kidney transplant patients","volume":"13","author":"Pham","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0235","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/TP.0000000000004297","article-title":"Infection, rejection, and the connection","volume":"107","author":"Higdon","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0240","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1017\/ice.2015.249","article-title":"Diabetes and risk of surgical site infection: a systematic review and meta-analysis","volume":"37","author":"Martin","year":"2016","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.trim.2025.102304_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-023-03338-4","article-title":"Prevalence and risk factors of urinary tract infection in kidney recipients: a meta-analysis study","volume":"24","author":"Hosseinpour","year":"2023","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb0250","first-page":"1488","article-title":"Diabetes mellitus as a predictive factor for urinary tract infection for patients treated with kidney transplantation","volume":"58","author":"Ozawa","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.trim.2025.102304_bb0255","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3390\/microorganisms12112217","article-title":"Urinary tract infections in kidney transplant patients: an open challenge\u2014update on epidemiology, risk factors management","volume":"12","author":"Pinchera","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.trim.2025.102304_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101798","article-title":"Infections after organ transplantation and immune response","volume":"77","author":"Elalouf","year":"2023","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jare.2023.05.009","article-title":"Novel ray of hope for diabetic wound healing: hydrogen sulfide and its releasing agents","volume":"58","author":"Shi","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.trim.2025.102304_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176645","article-title":"Healing the diabetic wound: unlocking the secrets of genes and pathways","volume":"975","author":"Kamal","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.trim.2025.102304_bb0275","first-page":"1072","article-title":"Diabetic wound-healing science","volume":"57","author":"Burgess","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.trim.2025.102304_bb0280","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/ph13040060","article-title":"The treatment of impaired wound healing in diabetes: looking among old drugs","volume":"13","author":"Spampinato","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.trim.2025.102304_bb0285","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0168-8278(96)80329-1","article-title":"Diabetes mellitus after liver transplantation: prevalence and predictive factors","volume":"25","author":"Navasa","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.trim.2025.102304_bb0290","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/01.tp.0000250361.60415.96","article-title":"Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up","volume":"82","author":"Moon","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0295","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.transproceed.2008.03.018","article-title":"Posttransplant diabetes mellitus: incidence and risk factors","volume":"40","author":"Mazali","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2025.102304_bb0300","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/jlts.2002.34638","article-title":"Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus","volume":"8","author":"John","year":"2002","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2025.102304_bb0305","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/clinem\/dgad395","article-title":"Posttransplant diabetes mellitus: recent developments in pharmacological management of hyperglycemia","volume":"109","author":"Munoz Pena","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0310","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2337\/dc12-1577","article-title":"Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases","volume":"36","author":"Park","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trim.2025.102304_bb0315","series-title":"Perioperative Management of Patients with Diabetes and Cancer: Challenges and Opportunities, Cancers 2024","first-page":"2821","volume":"16","author":"Shouman","year":"2024"},{"key":"10.1016\/j.trim.2025.102304_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-018-0268-9","article-title":"Postoperative tight glycemic control significantly reduces postoperative infection rates in patients undergoing surgery: a meta-analysis","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.trim.2025.102304_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/ags3.12006","article-title":"Strict glycemic control to prevent surgical site infections in gastroenterological surgery","volume":"1","author":"Takesue","year":"2017","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.trim.2025.102304_bb0330","doi-asserted-by":"crossref","first-page":"34","DOI":"10.31450\/ukrjnd.2(82).2024.06","article-title":"Prevalence and risk factors of new-onset diabetes after transplantation: a single-center experience","volume":"2024","author":"Akbay","year":"2024","journal-title":"Ukr. J. Nephrol. Dial."},{"key":"10.1016\/j.trim.2025.102304_bb0335","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2217\/dmt.11.33","article-title":"New-onset diabetes after transplantation: focus on treatment strategies","volume":"1","author":"Marino","year":"2011","journal-title":"Diabetes Manag."},{"key":"10.1016\/j.trim.2025.102304_bb0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/dc11-1230","article-title":"New-onset diabetes after renal transplantation: risk assessment and management","volume":"35","author":"Ghisdal","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trim.2025.102304_bb0345","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5125\/jkaoms.2023.49.6.311","article-title":"Review of two immunosuppressants: tacrolimus and cyclosporine","volume":"49","author":"Lee","year":"2023","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"key":"10.1016\/j.trim.2025.102304_bb0350","doi-asserted-by":"crossref","first-page":"81285","DOI":"10.18632\/oncotarget.18150","article-title":"Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trim.2025.102304_bb0355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00007890-201407151-00697","article-title":"Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients","volume":"98","author":"Notaro","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0360","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/ndt\/gfp778","article-title":"Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the symphony study","volume":"25","author":"Ekberg","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6002\/ect.2018.0337","article-title":"Conversion from cyclosporine to once-daily tacrolimus on 50:1 mg Basis: a short-term pilot study","volume":"18","author":"Shimada","year":"2020","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ckj\/sfab131","article-title":"Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics","volume":"15","author":"Montero","year":"2022","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.trim.2025.102304_bb0375","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1060028020951955","article-title":"Review of newer antidiabetic agents for diabetes Management in Kidney Transplant Recipients","volume":"55","author":"Anderson","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.trim.2025.102304_bb0380","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/life13061265","article-title":"Novel drugs for the Management of Diabetes Kidney Transplant Patients: a literature review","volume":"13","author":"Valencia-Morales","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.trim.2025.102304_bb0385","article-title":"Determinants of poor glycemic control in patients with kidney transplants: a single-center retrospective cohort study in Canada","volume":"7","author":"Kong","year":"2020","journal-title":"Can. J. Kidney Heal. Dis."},{"key":"10.1016\/j.trim.2025.102304_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-54171-8","article-title":"The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients","volume":"15","author":"Sheu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trim.2025.102304_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1180477","article-title":"Inpatient multidisciplinary care can prevent deterioration of renal function in patients with chronic kidney disease: a nationwide cohort study","volume":"14","author":"Abe","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.trim.2025.102304_bb0400","doi-asserted-by":"crossref","first-page":"619","DOI":"10.21037\/gs-23-116","article-title":"Application of a specialist nurse-led multidisciplinary team model in the perioperative care of patients undergoing simultaneous pancreas and kidney transplantation: randomized controlled trial","volume":"12","author":"Zhang","year":"2023","journal-title":"Gland Surg."},{"key":"10.1016\/j.trim.2025.102304_bb0405","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s13300-023-01416-2","article-title":"Optimizing multidisciplinary care of patients with chronic kidney disease and type 2 diabetes mellitus","volume":"14","author":"Kelepouris","year":"2023","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.trim.2025.102304_bb0410","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/ajt.14665","article-title":"Prospective randomized study of conversion from tacrolimus to cyclosporine a to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation","volume":"18","author":"Wissing","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0415","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/ijcp.12666","article-title":"Comparison of tacrolimus and cyclosporin a in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study","volume":"69","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.trim.2025.102304_bb0420","series-title":"Nephrol. Dial. Transplant","first-page":"531","article-title":"International consensus on post-transplantation diabetes mellitus","author":"Sharif","year":"2024"},{"key":"10.1016\/j.trim.2025.102304_bb0425","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/jhn.13354","article-title":"Hypomagnesaemia, an independent risk factor for the development of post-transplant diabetes mellitus in liver and renal transplant recipients? A systematic review","volume":"37","author":"Chen","year":"2024","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.trim.2025.102304_bb0430","first-page":"249","article-title":"Posttransplantation diabetes mellitus after liver transplant and the impact of family history of diabetes in a Mexican cohort","volume":"89","author":"Fern\u00e1ndez-Ram\u00edrez","year":"2024","journal-title":"Rev. Gastroenterol. M\u00e9xico (English Ed.)"},{"key":"10.1016\/j.trim.2025.102304_bb0435","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5500\/wjt.v11.i10.432","article-title":"Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: systematic review and meta-analysis","volume":"11","author":"Kotha","year":"2021","journal-title":"World J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0440","article-title":"New-onset diabetes mellitus in post-renal transplant patients on tacrolimus and mycophenolate: a systematic review","volume":"14","author":"Nandula","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.trim.2025.102304_bb0445","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2215\/CJN.05471008","article-title":"Hyperglycemia during the immediate period after kidney transplantation","volume":"4","author":"Chakkera","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb0450","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/clinpract14050156","article-title":"Management of Early Post-Transplant Hyperglycemia by dedicated endocrine care improves glycemic outcomes","volume":"14","author":"Kaplan","year":"2024","journal-title":"Clin. Pract."},{"key":"10.1016\/j.trim.2025.102304_bb0455","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1210\/js.2018-00227","article-title":"Hyperglycemia in the posttransplant period: NODAT vs posttransplant diabetes mellitus","volume":"2","author":"Gupta","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.trim.2025.102304_bb0460","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: results from the TANGO international transplant consortium","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0465","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/tri.13783","article-title":"Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics","volume":"34","author":"Hecking","year":"2021","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2025.102304_bb0470","article-title":"Diabetes management in the hospitalized patient","volume":"49","author":"Donaldson","year":"2024","journal-title":"U.S. Pharm."},{"key":"10.1016\/j.trim.2025.102304_bb0475","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S2213-8587(20)30381-8","article-title":"Management of diabetes and hyperglycaemia in the hospital","volume":"9","author":"Pasquel","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.trim.2025.102304_bb0480","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/ph17080987","article-title":"Managing post-transplant diabetes mellitus after kidney transplantation: challenges and advances in treatment","volume":"17","author":"Rudzki","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.trim.2025.102304_bb0485","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archsurg.141.4.375","article-title":"Long-term glycemic control and postoperative infectious complications","volume":"141","author":"Dronge","year":"2006","journal-title":"Arch. Surg."},{"key":"10.1016\/j.trim.2025.102304_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13741-023-00302-6","article-title":"Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery","volume":"12","author":"Sreedharan","year":"2023","journal-title":"Perioper. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0495","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/SLA.0b013e31827b6bbc","article-title":"Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program","volume":"257","author":"Kwon","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.trim.2025.102304_bb0500","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000522092","article-title":"Post-transplant diabetes: prevalence, risk, and management challenges","volume":"28","author":"Bashier","year":"2022","journal-title":"Dubai Diabetes Endocrinol."},{"key":"10.1016\/j.trim.2025.102304_bb0505","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/TP.0000000000003867","article-title":"Management of Diabetes in candidates for liver transplantation and in transplant recipients","volume":"106","author":"Brodosi","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0510","article-title":"Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: a single-center retrospective study, diabetes res","volume":"165","author":"Aleksic","year":"2020","journal-title":"Clin. Pract."},{"key":"10.1016\/j.trim.2025.102304_bb0515","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s13300-020-00790-5","article-title":"Post-transplantation diabetes mellitus","volume":"11","author":"Ahmed","year":"2020","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.trim.2025.102304_bb0520","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/er.2015-1084","article-title":"Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes","volume":"37","author":"Shivaswamy","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb0525","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000514288","article-title":"Post-transplant diabetes mellitus and prediabetes in renal transplant recipients: an update","volume":"145","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2021","journal-title":"Nephron"},{"key":"10.1016\/j.trim.2025.102304_bb0530","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.2021060777","article-title":"Prevention of post-transplantation diabetes: small steps, big opportunities","volume":"32","author":"Sharif","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb0535","first-page":"451","article-title":"Glycemic control reduces infections in post-liver transplant patients: results of a prospective, randomized study","volume":"102","author":"Wallia","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-015-0585-6","article-title":"Management of the Hospitalized Transplant Patient","volume":"15","author":"Boerner","year":"2015","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.trim.2025.102304_bb0545","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.2337\/dc16-S016","article-title":"Diabetes care in the hospital","volume":"39","author":"A.D. Association, 13","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trim.2025.102304_bb0550","first-page":"648","article-title":"Glucose management in hospitalized patients","volume":"96","author":"Kodner","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.trim.2025.102304_bb0555","author":"Diabetes Canada"},{"key":"10.1016\/j.trim.2025.102304_bb0560","series-title":"Diabetic Perioperative Management","author":"Dogra","year":"2019"},{"key":"10.1016\/j.trim.2025.102304_bb0565","article-title":"Management of diabetes and hyperglycemia in hospitalized patients","author":"Dhatariya","year":"2024","journal-title":"Endotext"},{"key":"10.1016\/j.trim.2025.102304_bb0570","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4093\/dmj.2015.39.4.273","article-title":"Glycemic variability: how do we measure it and why is it important?","volume":"39","author":"Suh","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.trim.2025.102304_bb0575","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1681\/ASN.2013040383","article-title":"Genetics of new-onset diabetes after transplantation","volume":"25","author":"McCaughan","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb0580","article-title":"Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia","volume":"21","author":"Mac Guad","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb0585","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jhep.2012.09.025","article-title":"Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population","volume":"58","author":"Ling","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.trim.2025.102304_bb0590","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/0366-6999.209886","article-title":"Gene variations of sixth complement component affecting tacrolimus metabolism in patients with liver transplantation for hepatocellular carcinoma","volume":"130","author":"Liao","year":"2017","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.trim.2025.102304_bb0595","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1499-3872(17)60069-9","article-title":"Association between ADIPOQ gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation","volume":"16","author":"Cen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.trim.2025.102304_bb0600","doi-asserted-by":"crossref","first-page":"375","DOI":"10.6002\/ect.2016.0205","article-title":"Glutathione S-transferase gene polymorphisms and the development of new-onset diabetes after liver transplant","volume":"17","author":"Musavi","year":"2019","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0605","series-title":"Kidney Transplant. - Princ. Pract","first-page":"517","article-title":"Infection in kidney transplant recipients","author":"Fishman","year":"2019"},{"key":"10.1016\/j.trim.2025.102304_bb0610","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0615","doi-asserted-by":"crossref","first-page":"E1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cNet State of Immunosuppression,\u201d","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2025.102304_bb0620","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/er.2015-1084","article-title":"Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes","volume":"37","author":"Shivaswamy","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb0625","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00203-020-01818-x","article-title":"Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies","volume":"202","author":"Akash","year":"2020","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.trim.2025.102304_bb0630","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.athoracsur.2009.10.054","article-title":"Intraoperative hyperglycemia and postoperative bacteremia in the pediatric cardiac surgery patient","volume":"89","author":"O\u2019Brien","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.trim.2025.102304_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1060283","article-title":"Association of intraoperative hyperglycemia with postoperative composite infection after cardiac surgery with cardiopulmonary bypass: a retrospective cohort study","volume":"9","author":"Xiong","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12871-020-01022-w","article-title":"Association of intraoperative hyperglycemia and postoperative outcomes in patients undergoing non-cardiac surgery: a multicenter retrospective study","volume":"20","author":"Shah","year":"2020","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.trim.2025.102304_bb0645","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5500\/wjt.v8.i3.75","article-title":"Perioperative glucose management and outcomes in liver transplant recipients: a qualitative systematic review","volume":"8","author":"Paka","year":"2018","journal-title":"World J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.559595","article-title":"Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia","volume":"9","author":"Ch\u00e1vez-Reyes","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.trim.2025.102304_bb0655","series-title":"J. Diabetes Sci","first-page":"1282","article-title":"Perioperative blood glucose monitoring in the general surgical population","author":"Raju","year":"2009"},{"key":"10.1016\/j.trim.2025.102304_bb0660","doi-asserted-by":"crossref","DOI":"10.53855\/bjt.v27i1.608_ENG","article-title":"Prophylaxis in kidney transplantation","volume":"27","author":"Cardoso","year":"2024","journal-title":"Brazilian J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-015-0513-6","article-title":"Infection prevention in transplantation","volume":"18","author":"Pergam","year":"2016","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.trim.2025.102304_bb0670","doi-asserted-by":"crossref","first-page":"057","DOI":"10.17352\/acn.000057","article-title":"Impact of diabetes mellitus on renal transplant outcome","author":"Muhammad Tanzeel","year":"2021","journal-title":"Arch. Clin. Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb0675","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jceh.2021.09.010","article-title":"An approach to the Management of Diabetes Mellitus in cirrhosis: a primer for the Hepatologist","volume":"12","author":"Puri","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.trim.2025.102304_bb0680","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.transproceed.2009.12.062","article-title":"Risk factors and outcomes associated with Posttransplant diabetes mellitus in kidney transplant recipients","volume":"42","author":"Siraj","year":"2010","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2025.102304_bb0685","first-page":"41","article-title":"Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation","volume":"54","author":"Pietrzak-Nowacka","year":"2008","journal-title":"Ann. Acad. Med. Stetin."},{"key":"10.1016\/j.trim.2025.102304_bb0690","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3748\/wjg.v18.i14.1642","article-title":"Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis","volume":"18","author":"Naing","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.trim.2025.102304_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678771","article-title":"A bittersweet response to infection in diabetes; targeting neutrophils to modify inflammation and improve host immunity","volume":"12","author":"Dowey","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0700","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/TP.0b013e3181c3c2ff","article-title":"Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection","volume":"89","author":"Wallia","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3483","article-title":"Neutrophils and their role in the aetiopathogenesis of type 1 and type 2 diabetes","volume":"38","author":"Giovenzana","year":"2022","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb0710","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00509-23","article-title":"Triple threat: how diabetes results in worsened bacterial infections","volume":"92","author":"Darwitz","year":"2024","journal-title":"Infect. Immun."},{"key":"10.1016\/j.trim.2025.102304_bb0715","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5812\/numonthly.10773","article-title":"Hyperglycemia after renal transplantation: frequency and risk factors","volume":"5","author":"Khalili","year":"2013","journal-title":"Nephrourol. Mon."},{"key":"10.1016\/j.trim.2025.102304_bb0720","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00007890-199805131-00591","article-title":"Hyperglycemia after renal transplantation","volume":"65","author":"Sabawi","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0725","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2230-8210.94253","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0730","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/jcm8010076","article-title":"Infections in patients with diabetes mellitus","volume":"8","author":"Rodrigues","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0735","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/jpm12010116","article-title":"Prevention of post-transplant diabetes mellitus: towards a personalized approach","volume":"12","author":"Ducloux","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0740","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.mcna.2013.03.002","article-title":"Infections in transplant patients","volume":"97","author":"Pagalilauan","year":"2013","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.trim.2025.102304_bb0745","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2025.102304_bb0750","doi-asserted-by":"crossref","DOI":"10.1097\/01.tp.0001067428.57292.09","article-title":"P.143: diabetes mellitus as a risk factor for urinary tract infections in kidney transplant recipients","volume":"108","author":"Krohmals","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0755","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ncpneph0278","article-title":"Diabetes mellitus increases the risk of infection following renal transplantation","volume":"2","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1292625","article-title":"Modulatory immune responses in fungal infection associated with organ transplant - advancements, management, and challenges","volume":"14","author":"Elalouf","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0765","series-title":"Transpl. Infect","first-page":"843","article-title":"Infection prevention and control issues after solid organ transplantation","author":"Banach","year":"2016"},{"key":"10.1016\/j.trim.2025.102304_bb0770","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10687","article-title":"Vaccine-preventable infections among solid organ transplant recipients in Switzerland","volume":"6","author":"Walti","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.trim.2025.102304_bb0775","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3390\/vaccines11101611","article-title":"Vaccination recommendations in solid organ transplant adult candidates and recipients","volume":"11","author":"Vigan\u00f2","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.trim.2025.102304_bb0780","doi-asserted-by":"crossref","first-page":"E1544","DOI":"10.1097\/TXD.0000000000001544","article-title":"Vaccination in kidney transplant candidates","volume":"9","author":"Gajurel","year":"2023","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.trim.2025.102304_bb0785","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.2147\/IDR.S427656","article-title":"Optimal perioperative antimicrobial management strategies of kidney transplant recipients guided by metagenomic next-generation sequencing of deceased donors\u2019 microbiology samples","volume":"16","author":"Rao","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.trim.2025.102304_bb0790","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/TP.0000000000001848","article-title":"Perioperative antibiotic prophylaxis to prevent surgical site infections in solid organ transplantation","volume":"102","author":"Anesi","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0795","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008597.pub2","article-title":"Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis","author":"Adamu","year":"2014","journal-title":"Cochrane Database Syst. Rev. 2014"},{"key":"10.1016\/j.trim.2025.102304_bb0800","author":"ACSQHC"},{"key":"10.1016\/j.trim.2025.102304_bb0805","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.idc.2021.04.005","article-title":"Health care environmental hygiene: new insights and Centers for Disease Control and Prevention guidance","volume":"35","author":"Carling","year":"2021","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.trim.2025.102304_bb0810","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13756-022-01185-w","article-title":"New frontiers in healthcare environmental hygiene: thoughts from the 2022 healthcare cleaning forum","volume":"12","author":"Peters","year":"2023","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.trim.2025.102304_bb0815","first-page":"1","article-title":"Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the healthcare infection control practices advisory committee (HICPAC)","volume":"52","author":"Sehulster","year":"2003","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.trim.2025.102304_bb0820","doi-asserted-by":"crossref","DOI":"10.1186\/s12995-023-00371-9","article-title":"Differential risk of SARS-CoV-2 infection by occupation: evidence from the virus watch prospective cohort study in England and Wales","volume":"18","author":"Beale","year":"2023","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.trim.2025.102304_bb0825","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/cid\/ciad388","article-title":"Active surveillance and contact precautions for preventing methicillin-resistant Staphylococcus aureus healthcare-associated infections during the COVID-19 pandemic","volume":"77","author":"Evans","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2025.102304_bb0830","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1086\/587901","article-title":"The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review","volume":"46","author":"McGinigle","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2025.102304_bb0835","article-title":"New-onset diabetes mellitus in post-renal transplant patients on tacrolimus and mycophenolate: A Systematic Review","volume":"14","author":"Nandula","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.trim.2025.102304_bb0840","series-title":"Nephrol. Dial. Transplant.","first-page":"531","article-title":"International consensus on post-transplantation diabetes mellitus","author":"Sharif","year":"2024"},{"key":"10.1016\/j.trim.2025.102304_bb0845","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13030413","article-title":"Current pharmacological intervention and medical management for diabetic kidney transplant recipients","volume":"13","author":"Klangjareonchai","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.trim.2025.102304_bb0850","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2147\/TCRM.S129327","article-title":"Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation","volume":"13","author":"Tarnowski","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.trim.2025.102304_bb0855","article-title":"Progress of new-onset diabetes after liver and kidney transplantation","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.trim.2025.102304_bb0860","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13300-018-0384-6","article-title":"EADSG guidelines: insulin therapy in diabetes","volume":"9","author":"Silver","year":"2018","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.trim.2025.102304_bb0865","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2022.829412","article-title":"Management of Hyperglycemia in hospitalized patients receiving parenteral nutrition","volume":"3","author":"Sch\u00f6nenberger","year":"2022","journal-title":"Front. Clin. Diabetes Healthc."},{"key":"10.1016\/j.trim.2025.102304_bb0870","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/TP.0000000000004373","article-title":"Sitagliptin versus placebo to reduce the incidence and severity of Posttransplant diabetes mellitus after kidney transplantation\u2014a single-center, randomized, double-blind controlled trial","volume":"107","author":"Delos Santos","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0875","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hep4.1876","article-title":"Personalizing diabetes Management in Liver Transplant Recipients: the new era for optimizing risk management","volume":"6","author":"Richardson","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.trim.2025.102304_bb0880","series-title":"Glucagon-like Peptide-1 Receptor Agonists (GLP1-RA), in: Diabetes Kidney Dis","first-page":"563","author":"Alicic","year":"2022"},{"key":"10.1016\/j.trim.2025.102304_bb0885","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5500\/wjt.v11.i3.70","article-title":"Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern: Meta-analysis and systematic review","volume":"11","author":"Kumar","year":"2021","journal-title":"World J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0890","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1097\/JS9.0000000000001135","article-title":"Impact of varied immunosuppressive agents and post-transplant diabetes mellitus on prognosis among diverse transplant recipients (experimental studies)","volume":"110","author":"Liu","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.trim.2025.102304_bb0895","article-title":"Post-transplant diabetes mellitus in kidney transplant recipients in Sudan: a comparison between tacrolimus and cyclosporine-based immunosuppression","volume":"14","author":"Yousif","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.trim.2025.102304_bb0900","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/ijot.ijot_14_18","article-title":"Fernando, prevalence and risk factors for posttransplant diabetes mellitus: data from government tertiary care center","volume":"12","author":"Jayam","year":"2018","journal-title":"Indian J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0910","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/lt.20634","article-title":"Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus","volume":"12","author":"Dumortier","year":"2006","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2025.102304_bb0915","first-page":"146","article-title":"Conversion from tacrolimus to cyclosporine a for new-onset diabetes after transplantation: a single-Centre experience in renal transplanted patients and review of the literature","volume":"21","author":"Ghisdal","year":"2008","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2025.102304_bb0925","first-page":"1185","article-title":"Hyperglycemia and hyperlipidemia with kidney or liver transplantation: a review","volume":"12","author":"D\u2019Elia","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.trim.2025.102304_bb0930","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1262-3636(06)72809-9","article-title":"Immunosuppressive drug-induced diabetes","volume":"32","author":"Penfornis","year":"2006","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0935","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3803\/EnM.2020.743","article-title":"Insulin secretion and insulin resistance trajectories over 1 year after kidney transplantation: a multicenter prospective cohort study","volume":"35","author":"Bang","year":"2020","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0940","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/clinem\/dgab697","article-title":"Early post-renal transplant hyperglycemia","volume":"107","author":"Iqbal","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.trim.2025.102304_bb0945","series-title":"Extending Medicare Cover. Prev. Other Serv.","first-page":"412","author":"Institute of Medicine (US) Committee on Medicare Coverage Extensions, Immunosuppressive Drugs for Transplant Patients","year":"2000"},{"key":"10.1016\/j.trim.2025.102304_bb0950","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00007890-199501270-00010","article-title":"Weaning of immunosuppression in long - term liver transplant recipients","volume":"59","author":"Ramos","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb0955","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1447-0594.2008.00477.x","article-title":"Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes","volume":"8","author":"Okamoto","year":"2008","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.trim.2025.102304_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101833","article-title":"Hypoglycemia with insulin in post-transplant diabetes mellitus","volume":"78","author":"Chandra","year":"2023","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb0965","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrc2051","article-title":"Immunostimulatory monoclonal antibodies for cancer therapy","volume":"7","author":"Melero","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trim.2025.102304_bb0970","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.3390\/jcm12227141","article-title":"Early exposure of kidney transplant recipients with chronic antibody-mediated rejection to tocilizumab\u2014a preliminary study","volume":"12","author":"Arriv\u00e9","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0975","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14853","article-title":"Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients","volume":"37","author":"Khairallah","year":"2023","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2025.102304_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.790547","article-title":"Tocilizumab in the treatment of chronic antibody-mediated rejection post kidney transplantation: clinical and histological monitoring","volume":"8","author":"Noble","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.trim.2025.102304_bb0985","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.healun.2023.05.012","article-title":"Tocilizumab for antibody-mediated rejection treatment in lung transplantation","volume":"42","author":"January","year":"2023","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb0990","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/ijms25041986","article-title":"Mesenchymal stromal cells derived from dental tissues: immunomodulatory properties and clinical potential","volume":"25","author":"Poblano-P\u00e9rez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2025.102304_bb0995","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.637725","article-title":"Immunomodulatory properties of mesenchymal stromal cells: an update","volume":"9","author":"M\u00fcller","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.trim.2025.102304_bb1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04327.x","article-title":"Immunomodulatory properties and therapeutic application of mesenchymal stem cells","volume":"164","author":"Shi","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb1005","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.trim.2025.102304_bb1010","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","article-title":"Mesenchymal stem cells and immunomodulation: current status and future prospects","volume":"7","author":"Gao","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trim.2025.102304_bb1015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41423-023-00998-y","article-title":"Immunomodulatory properties of mesenchymal stem cells\/dental stem cells and their therapeutic applications","volume":"20","author":"Li","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb1020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.molmed.2023.05.008","article-title":"Localized immunomodulation technologies to enable cellular and organoid transplantation","volume":"29","author":"Nash","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.trim.2025.102304_bb1025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1293762","article-title":"Challenges and opportunities in the islet transplantation microenvironment: a comprehensive summary of inflammatory cytokine, immune cells, and vascular endothelial cells","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb1030","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10217","article-title":"Mesenchymal stem cell-inspired microgel scaffolds to control macrophage polarization","volume":"6","author":"Caldwell","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.trim.2025.102304_bb1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148604","article-title":"Down-regulation of surface CD28 under belatacept treatment: an escape mechanism for antigen-reactive T-cells","volume":"11","author":"De Graav","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2025.102304_bb1040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40472-019-00260-3","article-title":"Belatacept and CD28 Costimulation blockade: preventing and reducing alloantibodies over the long term","volume":"6","author":"Parsons","year":"2019","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.trim.2025.102304_bb1045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210301","article-title":"Current status regarding immunosuppressive treatment in patients after renal transplantation","volume":"24","author":"Szumilas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2025.102304_bb1050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210301","article-title":"Current status regarding immunosuppressive treatment in patients after renal transplantation","volume":"24","author":"Szumilas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2025.102304_bb1055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.52604\/alt.23.0021","article-title":"Biological immunosuppressive agents used in liver transplantation","volume":"3","author":"Park","year":"2023","journal-title":"Ann. Liver Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2024.100856","article-title":"Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: a systematic review and meta-analysis","volume":"38","author":"Oliveras","year":"2024","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb1065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/nep.14035","article-title":"Personalized immunosuppression after kidney transplantation","volume":"27","author":"Cheung","year":"2022","journal-title":"Nephrology"},{"key":"10.1016\/j.trim.2025.102304_bb1070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/tri.12603","article-title":"Immunosuppressive minimization with mTOR inhibitors and belatacept","volume":"28","author":"Diekmann","year":"2015","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2025.102304_bb1075","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1111\/ajt.14353","article-title":"Belatacept combined with transient Calcineurin inhibitor therapy prevents rejection and promotes improved long-term renal allograft function","volume":"17","author":"Adams","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb1080","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.942665","article-title":"Belatacept in kidney transplantation: what are the true benefits? A systematic review","volume":"9","author":"Lombardi","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.trim.2025.102304_bb1085","doi-asserted-by":"crossref","first-page":"E1419","DOI":"10.1097\/TXD.0000000000001419","article-title":"Treatment of De novo renal transplant recipients with Calcineurin inhibitor-free, Belatacept plus Everolimus-based immunosuppression","volume":"9","author":"Ram Peddi","year":"2023","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.trim.2025.102304_bb0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph17124581","article-title":"Risk factors in and long-term survival of patients with post-transplantation diabetes mellitus: a retrospective cohort study","volume":"17","author":"Cheng","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.trim.2025.102304_bb0920","doi-asserted-by":"crossref","first-page":"426","DOI":"10.21147\/j.issn.1000-9604.2017.05.07","article-title":"A national report from China liver transplant registry: steroid avoidance after liver transplantation for hepatocellular carcinoma","volume":"29","author":"Wei","year":"2017","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.trim.2025.102304_bb1090","series-title":"U.S. Pharm","article-title":"Managing cardiovascular risk post transplant","volume":"46","author":"Ledan","year":"2021"},{"key":"10.1016\/j.trim.2025.102304_bb1095","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2215\/CJN.00520121","article-title":"Post-transplant cardiovascular disease","volume":"16","author":"Birdwell","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb1100","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/ijms22073422","article-title":"Diabetes and cardiovascular risk in renal transplant patients","volume":"22","author":"Rysz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2025.102304_bb1105","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.transproceed.2005.08.061","article-title":"Cardiovascular risk factors in diabetic patients with renal transplants","author":"D\u00edaz","year":"2005","journal-title":"Transplant. Proc., Elsevier"},{"key":"10.1016\/j.trim.2025.102304_bb1110","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1681\/ASN.2016050543","article-title":"Understanding trends in kidney function 1 year after kidney transplant in the United States","volume":"28","author":"Huang","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb1115","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1600-6143.2008.02414.x","article-title":"2202 kidney transplant recipients with 10 years of graft function: what happens next?","volume":"8","author":"Matas","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb1120","first-page":"98","article-title":"Kidney transplantation in patients with type 1 diabetes mellitus: long-term prognosis for patients and grafts., Korean","volume":"16","author":"Kim","year":"2001","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.trim.2025.102304_bb1125","article-title":"A comparative study on graft and overall survival rates between diabetic and nondiabetic kidney transplant patients through survival analysis","volume":"10","author":"Garc\u00eda-Padilla","year":"2023","journal-title":"Can. J. Kidney Heal. Dis."},{"key":"10.1016\/j.trim.2025.102304_bb1130","doi-asserted-by":"crossref","DOI":"10.1177\/14791641221137352","article-title":"Ten-year incidence of post-transplant diabetes mellitus in renal transplant patients","volume":"19","author":"Habibnia","year":"2022","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.trim.2025.102304_bb1135","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00007890-199304000-00015","article-title":"Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation","volume":"55","author":"Carroll","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102304_bb1140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hbpd.2021.02.006","article-title":"Diabetes mellitus is a risk factor of acute kidney injury in liver transplantation patients","volume":"20","author":"Wang","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.trim.2025.102304_bb1145","series-title":"StatPearls","article-title":"New onset diabetes after transplant","author":"Solhjoo","year":"2023"},{"key":"10.1016\/j.trim.2025.102304_bb1150","series-title":"U.S. Pharm","first-page":"42","article-title":"Diabetes mellitus post kidney transplant","volume":"49","author":"Ouellette","year":"2024"},{"key":"10.1016\/j.trim.2025.102304_bb1155","first-page":"179","article-title":"New guidance on post-transplant diabetes - DiabetesontheNet","author":"Chowdhury","year":"2021","journal-title":"J. Diabetes Nurs."},{"key":"10.1016\/j.trim.2025.102304_bb1160","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14523","article-title":"Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation","volume":"38","author":"Chowdhury","year":"2021","journal-title":"Diabet. Med."},{"key":"10.1016\/j.trim.2025.102304_bb1205","first-page":"1","article-title":"Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.trim.2025.102304_bb1175","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11564","article-title":"European Society of Organ Transplantation (ESOT) consensus statement on prehabilitation for solid organ transplantation candidates","volume":"36","author":"Annema","year":"2023","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2025.102304_bb1210","series-title":"Clin. Transplant.","article-title":"Foreword: 4th edition of the American Society of Transplantation Infectious Diseases Guidelines","volume":"33","author":"Green","year":"2019"},{"key":"10.1016\/j.trim.2025.102304_bb1215","article-title":"American Diabetes Association releases 2023 standards of Care in Diabetes to guide prevention, diagnosis, and treatment for people living with diabetes","year":"2023","journal-title":"Am. Diabetes Assoc."},{"key":"10.1016\/j.trim.2025.102304_bb1220","series-title":"Summary of Revisions: Standards of Care in Diabetes\u20142023, Diabetes Care","first-page":"S5","volume":"vol. 46","author":"Elsayed","year":"2023"},{"key":"10.1016\/j.trim.2025.102304_bb1225","series-title":"Introduction and Methodology: Standards of Care in Diabetes\u20142023, Diabetes Care","first-page":"S1","volume":"vol. 46","author":"Elsayed","year":"2023"},{"key":"10.1016\/j.trim.2025.102304_bb1235","series-title":"Recommendations on Post-Transplant Diabetes and Immunosuppressive Therapy","author":"American Transplant Congress","year":"2022"},{"key":"10.1016\/j.trim.2025.102304_bb1240","series-title":"EAU Guidelines on Renal Transplantation, Eur. Assoc. Urol","author":"Breda","year":"2022"},{"key":"10.1016\/j.trim.2025.102304_bb1165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.22141\/2307-1257.14.1.2025.494","article-title":"KDIGO 2025 Clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)","volume":"14","author":"Authors","year":"2025","journal-title":"Kidneys"},{"key":"10.1016\/j.trim.2025.102304_bb1170","author":"ESOT Guidelines"},{"key":"10.1016\/j.trim.2025.102304_bb1180","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000715","article-title":"AASLD AST practice guideline on adult liver transplantation: diagnosis and management of graft-related complications","author":"Te","year":"2025","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2025.102304_bb1185","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2024.07.032","article-title":"EASL clinical practice guidelines on liver transplantation","volume":"81","author":"De Martin","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.trim.2025.102304_bb1190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"EASL clinical practice guidelines: liver transplantation","volume":"64","author":"Burra","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.trim.2025.102304_bb1195","series-title":"Nephrol. Dial. Transplant.","first-page":"531","article-title":"International consensus on post-transplantation diabetes mellitus","author":"Sharif","year":"2024"},{"key":"10.1016\/j.trim.2025.102304_bb1200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/ckj\/sfae367","article-title":"Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES working group","volume":"18","author":"Laghrib","year":"2025","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.trim.2025.102304_bb1245","series-title":"New Type of Stem Cell Transplant Shows Promise in Type 1 Diabetes","author":"Myshko","year":"2025"},{"key":"10.1016\/j.trim.2025.102304_bb1250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1618086","article-title":"Immune-evasive beta cells in type 1 diabetes: innovations in genetic engineering, biomaterials, and computational modeling","volume":"16","author":"Karaoglu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb1255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355609","article-title":"Ethical and legislative advances in xenotransplantation for clinical translation: focusing on cardiac, kidney and islet cell xenotransplantation","volume":"15","author":"Hawthorne","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb1260","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00041.2023","article-title":"Physiological basis for xenotransplantation from genetically modified PIGS to humans","volume":"104","author":"Peterson","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.trim.2025.102304_bb1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.deman.2024.100247","article-title":"Innovative immunotherapies and emerging treatments in type 1 diabetes management","volume":"17","author":"Zarei","year":"2025","journal-title":"Diabetes Epidemiol. Manag."},{"key":"10.1016\/j.trim.2025.102304_bb1275","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061864","article-title":"Transplantation without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-Centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients","volume":"12","author":"Brook","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.trim.2025.102304_bb1280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/antib14020049","article-title":"Regulatory T cell in kidney transplant: the future of cell therapy?","volume":"14","author":"Matarneh","year":"2025","journal-title":"Antibodies"},{"key":"10.1016\/j.trim.2025.102304_bb1285","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.11.014","article-title":"Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants","volume":"6","author":"McCallion","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.trim.2025.102304_bb1290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12902-025-01997-y","article-title":"Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment?","volume":"25","author":"Ogieuhi","year":"2025","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.trim.2025.102304_bb1295","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2025.14565","article-title":"The last mile in Beta-cell replacement therapy for type 1 diabetes: time to grow up","volume":"38","author":"Piemonti","year":"2025","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2025.102304_bb1300","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12882-019-1557-x","article-title":"Prediction of kidney transplant outcome based on different DGF definitions in Chinese deceased donation","volume":"20","author":"Hu","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.trim.2025.102304_bb1305","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/ajt.14941","article-title":"Urinary metabolites predict prolonged duration of delayed graft function in DCD kidney transplant recipients","volume":"19","author":"Kostidis","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102304_bb1310","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/ijms26051960","article-title":"Trends in precision medicine and pharmacogenetics as an adjuvant in establishing a correct immunosuppressive therapy for kidney transplant: an up-to-date historical overview","volume":"26","author":"Belardi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2025.102304_bb1315","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1592134","article-title":"Impact of CYP3A5 1* and 3* single nucleotide variants on tacrolimus pharmacokinetics and graft rejection risk in pediatric kidney transplant patients","volume":"16","author":"Xajil-Ramos","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.trim.2025.102304_bb1320","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2125.2010.03711.x","article-title":"Emerging treatment options for type 2 diabetes","volume":"70","author":"Piya","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.trim.2025.102304_bb1325","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/diagnostics15030284","article-title":"New onset diabetes after organ transplantation: risk factors, treatment, and consequences","volume":"15","author":"Popovi\u2019c","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.trim.2025.102304_bb1330","article-title":"Multicentre placebo-controlled double-blinded phase II study of Lenvatinib efficacy in patients with locally advanced or metastatic GIST (gastrointestinal stromal tumor) after Imatinib\/Sunitinib failure","year":"2019","journal-title":"Case Med Res."},{"key":"10.1016\/j.trim.2025.102304_bb1335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811696","article-title":"Role of complement system in kidney transplantation: stepping from animal models to clinical application","volume":"13","author":"Qi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102304_bb1340","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/jpm14030322","article-title":"Exploring costimulatory blockade-based immunologic strategies in transplantation: are they a promising immunomodulatory approach for organ and vascularized composite Allotransplantation?","volume":"14","author":"Grosu-Bularda","year":"2024","journal-title":"J. Pers. Med."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T21:13:57Z","timestamp":1765055637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327425001327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":266,"alternative-id":["S0966327425001327"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2025.102304","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation in post-transplant diabetes mellitus: Challenges and management","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2025.102304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102304"}}